SYNACT PHARMA ApS
34459975ActiveClinical-stage biotech company developing innovative therapies to resolve inflammation.
Publicly traded biotechnology companysynactpharma.com
Oversikt
- 7
- Ansatte
- Ukjent
- Omsetning
- 2012
- Grunnlagt
Nøkkelbeslutningstakere
Ann Kristin Led
Chief Financial Officer
@synactpharma.com+45311XXXXX
Jeppe Øvlesen
Chief Executive Officer
@synactpharma.com+45284XXXXX
Roy Fleischmann
Advisory Board Member
Ravi Rao
Advisory Board Member
+14 flere kontakter i Funnelfeedr
Beskrivelse
SynAct Pharma is a clinical-stage biotechnology company based in Sweden and Denmark that focuses on developing innovative therapies to resolve inflammation rather than simply inhibiting it. Their lead drug candidate, Resomelagon (AP1189), is a once-daily oral therapy designed to selectively activate...
Novakand Pharma AB
BIOTAGE SWEDEN AB